Works matching IS 21989788 AND DT 2022 AND VI 9 AND IP 4
Results: 16
Acknowledgement to Referees.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 539, doi. 10.1007/s40801-022-00345-z
- Publication type:
- Article
Trends in the Use of Sedative-Hypnotics, Opioids, and Neuromuscular Blockers in Hospitalized Patients During the COVID-19 Pandemic: Observational Retrospective Study.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 629, doi. 10.1007/s40801-022-00337-z
- By:
- Publication type:
- Article
A Review of Research Studies Using Data from the Administrative Claims Databases in Japan.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 543, doi. 10.1007/s40801-022-00331-5
- By:
- Publication type:
- Article
Drug-Induced QT Prolongation and Torsade de Pointes in Spontaneous Adverse Event Reporting: A Retrospective Analysis Using the Japanese Adverse Drug Event Report Database (2004–2021).
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 551, doi. 10.1007/s40801-022-00328-0
- By:
- Publication type:
- Article
Real-World Patient Characteristics, Utilization Patterns, and Outcomes of US Patients with HR+, HER2− Metastatic Breast Cancer Treated with Abemaciclib.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 681, doi. 10.1007/s40801-022-00327-1
- By:
- Publication type:
- Article
Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 617, doi. 10.1007/s40801-022-00326-2
- By:
- Publication type:
- Article
Effect of Tolvaptan in Patients with Chronic Kidney Disease Stage G5, and Impact of Concomitant Use of Thiazide Diuretics: A Retrospective Cohort Study.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 649, doi. 10.1007/s40801-022-00325-3
- By:
- Publication type:
- Article
Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 659, doi. 10.1007/s40801-022-00324-4
- By:
- Publication type:
- Article
Prophylactic Antimicrobial Prescribing in Australian Residential Aged-Care Facilities: Improvement is Required.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 561, doi. 10.1007/s40801-022-00323-5
- By:
- Publication type:
- Article
Rituximab and Pyoderma Gangrenosum: An Investigation of Disproportionality Using a Systems Biology-Informed Approach in the FAERS Database.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 639, doi. 10.1007/s40801-022-00322-6
- By:
- Publication type:
- Article
Treatment Pathways and Health Outcomes of German Patients with Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Health Claims Data Analysis.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 577, doi. 10.1007/s40801-022-00320-8
- By:
- Publication type:
- Article
Retrospective Cohort Evaluating the Comparative Effectiveness of Ceftaroline and Daptomycin as First-Line Therapies for Inpatient Treatment of Diabetic Foot Infection in the United States Veterans Health Care System.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 609, doi. 10.1007/s40801-022-00319-1
- By:
- Publication type:
- Article
Increased Risk of Stroke Due to Non-adherence and Non-persistence with Direct Oral Anticoagulants (DOACs): Real-World Analyses Using a Nested Case–Control Study from The Netherlands, Italy and Germany.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 597, doi. 10.1007/s40801-022-00317-3
- By:
- Publication type:
- Article
Factors Associated with Discontinuation of Statin Therapy in Patients with Lymphoma Aged 80 Years and Older: A Retrospective Single-Institute Study.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 569, doi. 10.1007/s40801-022-00314-6
- By:
- Publication type:
- Article
Effectiveness and Safety of Filgrastim (Neupogen™) versus Filgrastim-aafi (Nivestim™) in Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia: An Observational Cohort Study.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 589, doi. 10.1007/s40801-022-00312-8
- By:
- Publication type:
- Article
Adverse Drug Events Related to Common Asthma Medications in US Hospitalized Children, 2000–2016.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 4, p. 667, doi. 10.1007/s40801-022-00304-8
- By:
- Publication type:
- Article